Clinical Trials

PV-10 in atopic dermatitis

Provectus Pharmaceuticals, Inc. begins phase 2 clinical trial for atopic dermatitis

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here